Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice
- PMID: 314874
- PMCID: PMC1537677
Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice
Abstract
The effects of the anti-tumour agent OK-432 on the immune response to hamster erythrocytes (HRBC) and nucleated chicken erythrocytes (CRBC) were studied in inbred SL mice. Mice were treated repeatedly with OK-432 before immunization with erythrocytes in saline. The cytotoxicity of CRBC-primed spleen cells, as demonstrated by 51Cr release from labelled CRBC, was markedly increased by treatment with OD-432. The delayed footpad reaction to CRBC was significantly augmented by treatment with OK-432. These results in mice indicate that OK-432 can enhance the cellular immune responses which require the contribution of T cells. Such an activation of T cells by OK-432 was observed in the humoral immune response to a trinitrophenyl group. Augmentation of anti-hapten antibody production, suggesting the enhancement of helper T cell activity by OK-432, was noticed after immunization with trinitrophenyl conjugated to erythrocytes. Furthermore, this enhancement of helper T cell activity by OK-432 was confirmed by utilizing an adoptive transfer system. These results support the possibility that T cell activation may be one of the important effects of OK-432 as an immunopotentiator.
Similar articles
-
Direct cytotoxicity against chicken erythrocytes in mice. I. Fundamental nature of T cell-mediated cytotoxicity.Immunology. 1977 Dec;33(6):895-905. Immunology. 1977. PMID: 304039 Free PMC article.
-
Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.J Natl Cancer Inst. 1980 Dec;65(6):1265-9. J Natl Cancer Inst. 1980. PMID: 7001124
-
Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. Suppression of generation of effector cells for pancreatic B cell destruction.J Immunol. 1990 Jan 1;144(1):136-41. J Immunol. 1990. PMID: 2295787
-
Augmentation by OK-432 of generation of culture-induced killer cells.Jpn J Exp Med. 1987 Jun;57(3):153-61. Jpn J Exp Med. 1987. PMID: 3682231
-
The cortex regulates the immune system and the activities of a T-cell specific immunopotentiator.Int J Neurosci. 1988 Mar;39(1-2):177-87. doi: 10.3109/00207458808985702. Int J Neurosci. 1988. PMID: 3290138 Review.
Cited by
-
Promotion of hepatic metastases by liver resection in the rat.Br J Cancer. 1992 Jun;65(6):794-7. doi: 10.1038/bjc.1992.170. Br J Cancer. 1992. PMID: 1616850 Free PMC article.
-
Immunological analysis and characterization of lymphocyte subsets in specimens of human hepatocellular carcinomas and metastatic liver cancers.Cancer Immunol Immunother. 1989;28(1):1-8. doi: 10.1007/BF00205793. Cancer Immunol Immunother. 1989. PMID: 2535791 Free PMC article.
-
Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study.Cancer Chemother Pharmacol. 1994;33(5):366-70. doi: 10.1007/BF00686264. Cancer Chemother Pharmacol. 1994. PMID: 8306409 Clinical Trial.
-
A controlled study of maintenance chemoimmunotherapy vs immunotherapy alone immediately following palliative gastrectomy and induction chemoimmunotherapy for advanced gastric cancer. Tokai cooperative study group for adjuvant chemoimmunotherapy of stomach cancer.Cancer Chemother Pharmacol. 1981;7(1):5-10. doi: 10.1007/BF00258205. Cancer Chemother Pharmacol. 1981. PMID: 6176354 Clinical Trial.
-
Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.Cancer Chemother Pharmacol. 1993;33(2):171-5. doi: 10.1007/BF00685337. Cancer Chemother Pharmacol. 1993. PMID: 8261578
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources